Image

Observational Secondary Data Study Describing Treatment With Dapagliflozin Among Adult Chronic Kidney Disease Patients

Study on Dapagliflozin treatment for adults with chronic kidney disease.

Recruiting
18-130 years
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study looks at how a drug called dapagliflozin is used by adults with chronic kidney disease (CKD). CKD means your kidneys aren't working as well as they should for at least 3 months. Dapagliflozin helps treat this condition, and we want to see how well it works in real life. This study doesn't give treatments but uses past medical records to gather information. It's being done in several countries in Central Eastern Europe, including Bulgaria and Poland. About 1,090 adults will be included.

Key Points:

  • This study lasts up to 12 months, looking at how dapagliflozin affects CKD patients.
  • It will use existing medical records, so no extra doctor visits are needed for participants.
  • Participants must be adults who started taking dapagliflozin at least 30 days ago.

Participants must be 18 or older and have started dapagliflozin treatment for CKD. If you have type 1 diabetes or have had a kidney transplant, you can't join. The study will help doctors understand better how this drug can help CKD patients.

Print
Study details
    Chronic Kidney Disease (CKD)

NCT06203704

AstraZeneca

24 January 2024

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.